Chronic Respiratory Disease in Rats — Management Guide

Comprehensive, practical guide to chronic respiratory disease in rats — Mycoplasma pulmonis, secondary infections, environmental triggers, antibiotics, nebulization and long‑term care.

Quick Overview

• What it is: Chronic respiratory disease in rats is most commonly caused by Mycoplasma pulmonis (a persistent bacterial infection) often complicated by secondary bacteria, poor husbandry (ammonia, dust) and viral or parasitic factors.
• Who’s at risk: Young and older rats, animals from multi‑rat facilities or breeders, crowded/poorly ventilated housing, and rats exposed to dusty or aromatic bedding (cedar/pine).
• Prognosis: Variable. Many rats respond clinically to antibiotic and supportive therapy but true eradication of M. pulmonis is difficult; relapses are common. With careful medical and environmental management, many rats maintain good quality of life for months–years.

Pathophysiology — explained simply

Mycoplasma pulmonis is a wall‑less bacterium that colonizes the upper and lower respiratory tract of rats. It attaches to mucosal surfaces and provokes a chronic inflammatory response. That inflammation thickens airways, produces mucus and impairs normal mucociliary clearance. Over time even low levels of bacteria and ongoing inflammation lead to chronic disease.

Secondary bacterial infections (e.g., Pasteurella spp., Corynebacterium, Streptococcus) commonly complicate mycoplasmosis. Environmental irritants — ammonia from urine, dusty or aromatic bedding, poor ventilation — damage airway lining and make infection and inflammation worse. The end result is a cycle: infection → inflammation → impaired clearance → colonization by opportunistic bacteria → more inflammation.

Breed-specific risk factors and prevalence

• No specific “breed” of fancy rats (Rattus norvegicus) is immune; all commonly kept varieties are susceptible.
• Prevalence is highest in multi‑rat housing, breeding facilities and laboratory colonies where M. pulmonis is endemic. Reported seroprevalence in large colonies can be high (many colonies have >30–70% exposure historically).
• Young rats are more likely to develop acute signs; older animals more often show chronic lesions (otitis media, bronchiectasis).

Symptoms and grading/stages

Common signs:

• Sneezing, nasal discharge (clear → mucopurulent)
• Snuffling, audible upper airway noise
• Ocular discharge, conjunctivitis
• Wheeze, crackles on auscultation
• Reduced activity, inappetence, weight loss
• Severe disease: increased respiratory effort, open‑mouth breathing, cyanosis

• Stage 0 — exposed, no signs
• Stage 1 (mild) — intermittent sneezing, clear nasal/ocular discharge, normal appetite
• Stage 2 (moderate) — persistent mucopurulent discharge, audible wheeze, reduced activity, mild weight loss
• Stage 3 (severe) — tachypnea, dyspnea, open‑mouth breathing, anorexia, systemic illness

Diagnostic approach

Goal: confirm infection/inflammation, identify secondary pathogens, and assess severity.

History and physical exam

• Ask about onset, housing, other rats affected, bedding type, cleaning schedule, and previous treatments.
• Auscultate for wheezes/crackles and palpate for facial swelling (sinusitis/otitis).

• Basic bloodwork (CBC) if available — may show neutrophilia with secondary bacterial infection.
• Thoracic radiographs (two views) — useful to identify bronchiectasis, consolidation, or severe pneumonia.

• PCR on nasal/choanal swab or tracheal wash for Mycoplasma pulmonis — PCR is sensitive and commonly used in referral labs.
• Bacterial culture and sensitivity from nasal/tracheal swab or tracheal wash — to detect secondary bacteria and guide antibiotic selection.
• Cytology of secretions — evaluates inflammation type (neutrophilic suggests bacterial superinfection).

• CT scan can more precisely evaluate bronchiectasis and parenchymal disease (referral hospitals).
• Referral to a veterinarian with exotic/small mammal internal medicine experience for complicated, non‑responsive, or severe cases.

Treatment options

Principles: reduce microbial load, control secondary bacteria, interrupt inflammation, support airway clearance and overall health.

Medical therapy — antibiotics

1) Doxycycline

• Common dose: 5–10 mg/kg PO every 12–24 hours (typical starting dose 10 mg/kg PO q24h or 5 mg/kg q12h). Duration: at least 3–6 weeks for clinical improvement; longer courses (6–8+ weeks) commonly needed because Mycoplasma hides in tissues.
• Notes: Doxycycline is bacteriostatic against Mycoplasma and has anti‑inflammatory properties. Use with food if GI upset occurs. Avoid dosing stress and always follow prescription from your vet.

• Common dose: 5–10 mg/kg PO every 12–24 hours. Often used in combination for suspected or confirmed secondary Gram‑negative infections or when culture indicates susceptibility.
• Notes: Fluoroquinolones provide bactericidal activity against many opportunistic bacteria but are less consistently effective against Mycoplasma alone. Use cautiously (risk of cartilage effects in growing animals is theoretical for small mammals; discuss with your vet).

• Many clinicians use doxycycline plus enrofloxacin or another appropriate antibiotic sequentially or in combination for severe, refractory cases. Combination can target Mycoplasma plus secondary pathogens. Monitor clinical response and adjust based on culture/sensitivity.

• Azithromycin or tylosin (macrolides) are sometimes used; azithromycin dosing typically 10–20 mg/kg PO once daily for several days then every other day, but use only as directed by your vet.

• Nebulization (aerosol therapy): 0.9% saline nebulization 10–15 minutes twice daily helps loosen secretions and improve clearance; addition of nebulized bronchodilators (e.g., salbutamol/albuterol in vet‑formulated doses) may help bronchospasm. Nebulized antibiotics (gentamicin) are used in some referral settings but require strict dosing and monitoring.
• Mucolytics: N‑acetylcysteine (NAC) is sometimes used to thin mucus; discuss safe formulations and doses with your vet.
• Fluids and nutritional support: force‑feeding high‑calorie gels or syringe feeding if anorexic; subcutaneous fluids for dehydrated animals.
• Environmental management (see below) — essential component of treatment.

• Generally avoided because they suppress immune response; may be considered short‑term in severe inflammatory airway disease under specialist guidance.

• Rarely required. Indications: discrete abscesses, severe otitis media with neurologic signs, or airway obstruction amenable to surgery.

• Humidification (steamy bathroom, nebulizer sessions) improves comfort.
• Probiotics are sometimes recommended during prolonged antibiotic therapy to reduce GI upset; evidence is limited.

• Antibiotics and supportive care can markedly improve clinical signs in a majority of rats (many clinical reports cite substantial symptomatic improvement), but complete eradication of M. pulmonis is uncommon in endemic colonies. Relapses are common if environmental triggers persist.

Nebulization — practical guidance

• Purpose: loosen mucus, hydrate airways, deliver bronchodilators/medications locally and improve mucociliary clearance.
• Device: small ultrasonic or mesh nebulizer suitable for small animal enclosures or an appropriately sized chamber.
• Typical regimen: 10–15 minutes, 1–2 times daily for maintenance; 2–3 times daily during acute exacerbations — follow your vet’s protocol.
• Solutions: 0.9% saline is safe; bronchodilator solutions (albuterol) and vet‑prescribed nebulized antibiotics (rare) only under veterinary guidance.
• Safety: monitor temperature, stress level and breathing during sessions. Avoid forcing an animal into a tiny space — sessions should be calm and supervised.

Long-term management and monitoring

• Environmental control: reduce ammonia and dust — daily spot cleaning, full cage clean at least weekly, use low‑dust, unscented paper or hemp bedding. Avoid cedar and pine shavings.
• Ventilation: keep housing in a well‑ventilated, draft‑free room with stable temperature (18–24°C / 65–75°F) and moderate humidity (40–60%).
• Avoid irritants: smoke, aerosols, strong cleaning agents, and perfume.
• Routine checks: monitor body weight weekly and resting respiratory rate (count flank movements for 15 sec ×4) and document baseline with your vet. Recheck visits every 2–4 weeks initially, then every 3 months once stable.
• Long antibiotic courses: if long‑term or repeated courses are needed, discuss hepatic/renal monitoring and gastrointestinal support with your vet.
• Isolation and prevention: if you keep multiple rats and infection is confirmed, discuss testing and treatment of cagemates and brood animals with your vet to reduce reinfection risk.

Prognosis and quality of life

• Mild to moderate disease: many rats do well long‑term with environmental adjustments and periodic antibiotics; quality of life can be good for months to years.
• Severe disease (Stage 3): guarded to poor if there is marked parenchymal lung disease, persistent hypoxia or severe weight loss despite treatment.
• Focus on comfort: when clinical control fails and quality of life deteriorates (poor appetite, constant labored breathing), humane euthanasia may be the kindest option. Discuss this with your veterinarian.

Living With Chronic Respiratory Disease — practical daily tips

• Daily: monitor appetite, activity and breathing rate; remove wet bedding and clean soiled areas promptly.
• Bedding: switch to low‑dust paper, fleece liners or as advised by your vet. Avoid cedar/pine and dusty substrates.
• Nebulizer: run short saline nebulization sessions (10 minutes) once or twice daily as recommended.
• Feeding: offer warm, palatable, calorie‑dense foods and hand feed if needed. Maintain fresh water and consider wetening pellets to increase palatability.
• Temperature and humidity: avoid cold drafts; a small hide box with soft bedding helps conserve heat. Keep humidity moderate; very high humidity can promote bacterial growth.
• Stress reduction: minimize handling during flareups and keep routine predictable.

When to See Your Vet Urgently

Seek immediate veterinary care if your rat has any of the following:

• Open‑mouth breathing or obvious difficulty breathing
• Blue or purple gums/tongue (cyanosis)
• Collapse, severe lethargy or seizures
• Rapid unresponsive weight loss (>10–20% body weight) or refusal to eat for >24 hours
• Persistent high respiratory rate at rest or increased effort despite home treatments

References and further reading

• American College of Veterinary Internal Medicine (ACVIM) resources on respiratory infections and exotic companion mammals — consult an ACVIM diplomate in exotics when available: https://www.acvim.org
• Laboratory Animal Medicine (Fox JG, Anderson LC, Otto GM, Pritchett‑Corning KR, Whary MT) — textbook chapters on mycoplasmosis and respiratory disease.
• Peer‑reviewed veterinary literature on Mycoplasma pulmonis and respiratory disease in rodents; small mammal/exotics journals and specialty guidelines.

Frequently Asked Questions